Evora Biosciences, Orixha and Icon Photonics among the 100 start-ups to invest in in 2022 (Challenges)

24 March 2022

For the thirteenth consecutive year, Challenges has published its selection of “100 start-ups to invest in”.

The start-ups from Erganeo, Orixha, Evora Biosciences and Icon Photonics are included for this year 2022 in the Deeptech, Medtech and Biotech sectors.

  • Evora Biosciences develops exosome-based treatments, the next generation of subcellular therapies. (Université Paris Cité)
    More details
  • Orixha has developed a solution for the health of the critical patient, thanks to Total Liquid Ventilation. This medical device is unique in the world.
    More details
  • Icon Photonics offers innovative solutions in the fields of optical coupling and encapsulation. (Gustave Eiffel University)
    More details

Erganeo congratulates its start-ups for this nomination.

Suivez-nous

Inscrivez-vous à notre Newsletter pour ne rien manquer de nos actualités